---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-015885"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2021-11-15T23:59:59+00:00"
generated_at: "2026-06-28T08:18:31.342557+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Kala acquires Combangio for $5M cash, $16.1M stock; board adds Blumenkranz

## Summary
- Upfront payment $5.0M cash + 7,788,667 shares (~$16.1M) representing 11.9% of Kala's outstanding.
- Contingent consideration up to $105M in milestones plus tiered mid-to-high single-digit royalties on KPI-012 sales.
- Board appoints Mark Blumenkranz, former Combangio board member, as Class II director; receives option for 42,000 shares.
- Kala terminates Watertown lease, receives $2M termination consideration; HQ moves to Arlington, MA; outsources lab activities.

## SEC filing metadata
- accession: 0001558370-21-015885
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2021-11-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 1.02, 2.01, 2.02, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000155837021015885/0001558370-21-015885-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000155837021015885/kala-20211112x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-015885
- JSON: https://secwatch.observer/filing/0001558370-21-015885.json
- Plain text: https://secwatch.observer/filing/0001558370-21-015885.txt

## Key facts
- Executive change
  Mark Blumenkranz was appointed as Director at KALA BIO, Inc..
  - Action: appointed
  - Role: Director
  source text: Upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”), the Board appointed Mark Blumenkranz as a member of the Board, effective upon the Closing of the Acquisition
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837021015885/0001558370-21-015885-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.